These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2904097)

  • 1. Increased kynurenic acid levels in Huntington's disease.
    Connick JH; Stone TW; Carla V; Moroni F
    Lancet; 1988 Dec; 2(8624):1373. PubMed ID: 2904097
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical abnormalities in Huntington's disease: neurotoxic mechanisms and neurotransmitter changes.
    Reynolds GP; Pearson SJ
    J Neurol Sci; 1992 Dec; 113(2):230-3. PubMed ID: 1362587
    [No Abstract]   [Full Text] [Related]  

  • 3. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.
    Zwilling D; Huang SY; Sathyasaikumar KV; Notarangelo FM; Guidetti P; Wu HQ; Lee J; Truong J; Andrews-Zwilling Y; Hsieh EW; Louie JY; Wu T; Scearce-Levie K; Patrick C; Adame A; Giorgini F; Moussaoui S; Laue G; Rassoulpour A; Flik G; Huang Y; Muchowski JM; Masliah E; Schwarcz R; Muchowski PJ
    Cell; 2011 Jun; 145(6):863-74. PubMed ID: 21640374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of kynurenic acid levels in rat brain microdialysis samples and changes in kynurenic acid levels induced by N-acetylaspartic acid.
    Tomiya M; Fukushima T; Ogaya T; Sone Y; Mitsuhashi S; Toyo'oka T
    Biomed Chromatogr; 2010 Jun; 24(6):569-73. PubMed ID: 19816853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
    Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
    Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain GABA levels in asymptomatic Huntington's disease.
    Reynolds GP; Pearson SJ
    N Engl J Med; 1990 Sep; 323(10):682. PubMed ID: 2143559
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional changes in kynurenic acid, quinolinic acid, and glial fibrillary acidic protein concentrations in the fetal sheep brain after experimentally induced placental insufficiency.
    Nicholls T; Lacey B; Nitsos I; Smythe G; Walker DW
    Am J Obstet Gynecol; 2001 Jan; 184(2):203-8. PubMed ID: 11174503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micromolar concentration of kynurenic acid in rat small intestine.
    Kuc D; Zgrajka W; Parada-Turska J; Urbanik-Sypniewska T; Turski WA
    Amino Acids; 2008 Aug; 35(2):503-5. PubMed ID: 18235993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased brain 3-hydroxykynurenine in Huntington's disease.
    Reynolds GP; Pearson SJ
    Lancet; 1989 Oct; 2(8669):979-80. PubMed ID: 2571888
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant DNA studies on stored necropsy brain samples from patients with Huntington's chorea.
    Upadhyaya M; Reynolds GP; Harper PS
    J Clin Pathol; 1985 Oct; 38(10):1093-5. PubMed ID: 2932475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro.
    Parada-Turska J; Rzeski W; Zgrajka W; Majdan M; Kandefer-Szerszeń M; Turski W
    Rheumatol Int; 2006 Mar; 26(5):422-6. PubMed ID: 16220290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.
    Guidetti P; Luthi-Carter RE; Augood SJ; Schwarcz R
    Neurobiol Dis; 2004 Dec; 17(3):455-61. PubMed ID: 15571981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Translational Analysis of Brain Kynurenic Acid Modulation via Irreversible Kynurenine Aminotransferase II Inhibition.
    Chang C; Fonseca KR; Li C; Horner W; Zawadzke LE; Salafia MA; Welch KA; Strick CA; Campbell BM; Gernhardt SS; Rong H; Sawant-Basak A; Liras J; Dounay A; Tuttle JB; Verhoest P; Maurer TS
    Mol Pharmacol; 2018 Aug; 94(2):823-833. PubMed ID: 29853495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography.
    Shibata K
    J Chromatogr; 1988 Sep; 430(2):376-80. PubMed ID: 3235510
    [No Abstract]   [Full Text] [Related]  

  • 18. [Huntington's disease--review on neuroscientific approaches].
    Kanazawa I
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1815-25. PubMed ID: 6241961
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice.
    Guidetti P; Bates GP; Graham RK; Hayden MR; Leavitt BR; MacDonald ME; Slow EJ; Wheeler VC; Woodman B; Schwarcz R
    Neurobiol Dis; 2006 Jul; 23(1):190-7. PubMed ID: 16697652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reserpine action in Huntington's chorea.
    Calabrese VP
    N Engl J Med; 1973 Jul; 289(2):104. PubMed ID: 4267988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.